diacetylfluorescein has been researched along with daunorubicin in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ekberg, M; Larsson, R; Nygren, P; Slater, L | 1 |
| Hamburger AW Nora, RE; Joneckis, CC; Nora, RE; Ordóñez, JV; Ross, DD; Sisk, AM; Wu, RK | 1 |
| Fridborg, H; Killander, A; Kristensen, J; Larsson, R; Liliemark, J; Nygren, P; Oberg, G; Simonsson, B | 1 |
3 other study(ies) available for diacetylfluorescein and daunorubicin
| Article | Year |
|---|---|
Chemotherapeutic drug sensitivity testing of human leukemia cells in vitro using a semiautomated fluorometric assay.
Topics: Cell Count; Cell Survival; Daunorubicin; Drug Resistance; Drug Screening Assays, Antitumor; Fluoresceins; Fluorometry; Humans; Leukemia; Leukemia, Myeloid; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Tumor Cells, Cultured; Vincristine | 1990 |
Estimation of cell survival by flow cytometric quantification of fluorescein diacetate/propidium iodide viable cell number.
Topics: Animals; Antineoplastic Agents; Cell Count; Cell Cycle; Cell Line; Cell Survival; Dactinomycin; Daunorubicin; Flow Cytometry; Fluoresceins; Humans; Indicators and Reagents; Propidium; Tumor Stem Cell Assay; Vincristine | 1989 |
Interactions between cladribine (2-chlorodeoxyadenosine) and standard antileukemic drugs in primary cultures of human tumor cells from patients with acute myelocytic leukemia.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amsacrine; Antineoplastic Agents; Cladribine; Cytarabine; Daunorubicin; Drug Interactions; Drug Screening Assays, Antitumor; Drug Synergism; Etoposide; Female; Fluoresceins; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Mitoxantrone; Tumor Cells, Cultured | 1994 |